Skip to main content

Beth Jones Sanborn

By Beth Jones Sanborn | 04:52 pm | July 27, 2017
Settlement resolves allegations that Celgene promoted cancer drugs Thalomid, Revlimid for uses not approved by the FDA.
By Beth Jones Sanborn | 03:31 pm | July 27, 2017
Company has been on downward financial slope for months, cites dropping patient admissions as cause.
By Beth Jones Sanborn | 04:37 pm | July 26, 2017
Boston Children's will join Cleveland Clinic's network of cardiovascular care providers, hospital says.
By Beth Jones Sanborn | 01:27 pm | July 26, 2017
Expense growth and charges tied to broad EHR installations hurt the company's bottom line, despite revenue gains.
By Beth Jones Sanborn | 03:28 pm | July 25, 2017
Blood transfusions cost roughly $1,000 per unit, including both direct and indirect costs, Premier said.
By Beth Jones Sanborn | 12:18 pm | July 25, 2017
Expanded relationship includes CVS Health joining Cleveland Clinic's Quality Alliance.
By Beth Jones Sanborn | 04:09 pm | July 24, 2017
During their May earnings call, CHS reported a net loss of $199 million, compared with 2016 net income of $11 million.
By Beth Jones Sanborn | 02:56 pm | July 24, 2017
System cited increasing financial challenges, had invested $68 million in recent years in hopes of securing its future.
By Beth Jones Sanborn | 03:56 pm | July 21, 2017
Hospital will now be known as NYU Langone Hospital-Brooklyn, the system announced.
By Beth Jones Sanborn | 12:58 pm | July 21, 2017
Office was part of massive nationwide healthcare fraud takedown where more than 400 were charged, including 15 in their district.